Cipla Tofacitinib Tabletd IP 5 mg Tofajak

Send Inquiry

Request To Call Back

Cipla Tofacitinib Tabletd IP 5 mg Tofajak

Name: Cipla Tofacitinib Tabletd IP 5 mg Tofajak
Brand: ONCOTRUST
Price: 950.0 INR
Availability: InStock

Get a Price/Quote

MOQ : 1 Bottle

Cipla Tofacitinib Tabletd IP 5 mg Tofajak Specification

Life Span
Refer to expiry/manufacture date on pack

Salt Composition
Tofacitinib 5 mg

Packaging Type
Bottle

Indication
Rheumatoid arthritis, Psoriatic arthritis, Ulcerative colitis (see product literature)

Pacakaging (Quantity Per Box)
60 Tablets per bottle/box

Brand Name
Tofacitinib

Origin of Medicine
India

Dosage Form
Oral Tablets

Drug Type
Allopathic

Ingredients
Tofacitinib

Physical Form
Tablet

Function
Disease Modifying Anti-rheumatic Drug (DMARD), Immunomodulator

Recommended For
Adults

Dosage
5 mg per tablet; as prescribed by physician

Dosage Guidelines
Follow doctors prescription

Suitable For
Adults

Quantity
1 Unit

Storage Instructions
Store in a cool, dry place, below 30C

Route of Administration
Oral

Storage Condition
Protect from light and moisture

MRP Status
As per pack/region

Contraindications
Hypersensitivity to tofacitinib or any excipients

Common Side Effects
Headache, diarrhea, increased cholesterol, hypertension (see labeling for full list)

Appearance
White to off-white tablet

Prescription Required
Yes

Special Precautions
Use caution in liver or kidney impairment; routine blood monitoring advised

Therapeutic Class
Janus Kinase (JAK) inhibitor

Cipla Tofacitinib Tabletd IP 5 mg Tofajak Trade Information

Minimum Order Quantity
1 Bottle

Delivery Time
24 Hours

Cipla Tofacitinib Tabletd IP 5 mg Tofajak About

Tofacitinib Tablets IP 5 mg (Brand: Tofajak) is a prescription medication manufactured by Cipla Ltd., widely used in the treatment of autoimmune and inflammatory disorders. It belongs to the class of Janus Kinase (JAK) inhibitors, which work by modulating the immune system and reducing inflammation.

Tofajak is commonly prescribed for patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative Colitis, especially in cases where conventional therapies have shown inadequate response.

Indications / Uses:

Rheumatoid Arthritis
Psoriatic Arthritis
Ulcerative Colitis
Other autoimmune inflammatory conditions (as prescribed)

Benefits:

Helps reduce joint pain, swelling, and stiffness
Controls inflammation at the cellular level
Improves mobility and quality of life
Trusted Cipla quality and compliance

Dosage & Administration:

Dosage should be taken strictly as directed by a registered medical practitioner.

Storage Instructions:

Store in a cool, dry place
Protect from light and moisture
Keep out of reach of children

Mechanism of Action and Therapeutic Benefits

Tofacitinib, the active ingredient in Tofajak, acts as a Janus Kinase (JAK) inhibitor, disrupting specific pathways involved in inflammation and immune response. This mechanism helps control symptoms and progression of autoimmune conditions like rheumatoid arthritis and ulcerative colitis, ultimately reducing pain, swelling, and joint damage.

Proper Usage and Dosage Guidelines

Tofajak is intended for oral administration and should be taken exactly as prescribed, typically at a dose of 5 mg per tablet. Patients must not adjust their dosage without consulting their physician. Adherence to dosing schedules and prescribed durations enhances treatment outcomes and safety.

Safety, Storage, and Handling

It is crucial to store Tofajak tablets in a cool and dry place, below 30C, away from direct light and moisture. Routine blood tests are recommended due to the risk of side effects such as headache, diarrhea, or increased cholesterol. The medication is unsuitable for individuals with known hypersensitivity to Tofacitinib or its excipients.

FAQ's of Cipla Tofacitinib Tabletd IP 5 mg Tofajak:

Q: How should Tofajak 5 mg tablets be taken for best results?

A: Tofajak should be taken orally at the dose prescribed by your doctor, typically with or without food. Do not alter the dose or frequency without consulting your healthcare provider. Swallow the tablet whole with water, and follow all dosing instructions provided.

Q: What conditions can Tofajak 5 mg be used to treat?

A: Tofajak is indicated for adults suffering from rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, as outlined in the product literature. Its use relies on a physician's diagnosis and prescription.

Q: When should I seek medical advice while taking Tofajak?

A: Contact your doctor immediately if you experience severe or unexpected side effects such as persistent headache, diarrhea, unusual blood pressure changes, or signs of an allergic reaction. Routine check-ups and blood tests are essential for monitoring your health during therapy.

Q: Where should I store my Tofajak tablets?

A: Store Tofajak tablets in their original bottle, in a cool and dry environment below 30C, away from direct light and moisture. Keep the medication out of reach of children.

Q: What is the recommended process if a dose is missed?

A: If you miss a dose, take it as soon as you remember, unless it is nearly time for your next scheduled dose. Do not double up doses. Consult your physician if unsure about missed doses.

Q: What are the main benefits of using Tofajak for eligible adults?

A: Tofajak can help reduce pain, swelling, and disease progression in autoimmune conditions. It may improve joint function and quality of life in patients responding to the therapy under medical supervision.

Q: Are there any specific precautions or contraindications for using Tofajak?

A: Yes, Tofajak should not be used by individuals with hypersensitivity to Tofacitinib or any excipients, and caution is required for those with liver or kidney impairment. Routine blood monitoring is advised to ensure safety.

Tell us about your requirement